Silvant Capital Management LLC Neurocrine Biosciences Inc Transaction History
Silvant Capital Management LLC
- $2.23 Billion
- Q3 2024
A detailed history of Silvant Capital Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Silvant Capital Management LLC holds 21,833 shares of NBIX stock, worth $2.78 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
21,833
Previous 21,833
-0.0%
Holding current value
$2.78 Million
Previous $3.01 Million
16.37%
% of portfolio
0.11%
Previous 0.14%
Shares
5 transactions
Others Institutions Holding NBIX
# of Institutions
627Shares Held
94.3MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.8 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.27 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$654 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$327 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$237 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...